XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 31.16

-3.2%

Dec 1 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert K. who wrote (16465)	11/22/2003 9:57:57 AM
From: Robert K.	of 17367

George> I sense you coming to your senses. If I were you, I would take the fab opportunity you have, Geez....what luck. > and George> the BPI story STILL is very good IMO. Blue> the last line is true , but its what I have been saying all along. Its (for now) a 2 horse race. Enbrel & raptiva. Not bad company to be in. Not bad company to be compared with. As you know, each has its place TNF vs T-cell. Look how enrel has grown and is growing and expannding. Look for Rap to do same-same. Two drugs in a huge immunological market changing the treatment standards. Move over Cyclosporin & mtx. skd.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next